论文部分内容阅读
Ｃａｎｃｅｒ( 1999,86∶415 )载 ,台湾Ｙａｎｇ等报告 ,大剂量他莫昔芬可以安全地和顺铂及依托泊苷合用治疗不能手术的晚期非小细胞肺癌病人 ,疗效满意。对于不能手术的ⅢＢ期、Ⅳ期及复发的非小细胞肺癌病人联合化疗虽不能治愈 ,但可减轻症状 ,延长生存期。耐药是肿瘤化疗的
Cancer (1999,86: 415), Taiwan, Yang et al reported that high-dose tamoxifen can be safely combined with cisplatin and etoposide in the treatment of inoperable advanced non-small cell lung cancer patients with satisfactory results. For inoperable ⅢB, Ⅳ and recurrent non-small cell lung cancer patients combined chemotherapy can not be cured, but can reduce symptoms and prolong survival. Drug resistance is cancer chemotherapy